Connect to other sites within the UBM Medica Network
The sodium glucose cotransporter-2 inhibitors are the newest diabetes drugs available. Have you got the basic concepts under your belt? Try these 6 questions and find out.
Indications and Mechanism of SGLT2 Inhibitors in Type 2 Diabetes
This quiz will help you better assess whether or not to prescribe an SGLT2 inhibitor for your type 2 diabetes patients.
Pay-for-Performance in Endocrinology
How will pay-for-performance affect specialists who treat the more challenging patients? Our blogger shares her thoughts and concerns.
Inhaled Insulin: a Promising Option with Room for Growth?
Advances in delivery methods renewed interest in the development of an inhaled form of insulin. We explore the history, pros and cons, and future of this fast-acting, short-duration drug.
3 Weighty Questions About Obesity and Diabetes
Questions you were afraid to ask about weight-loss modalities in the context of obesity and type 2 diabetes are answered here.
Catch up on some of the latest headlines in diabetes care, including updates in pediatric management and an artificial pancreas.
Combo Diet-Exercise Programs Trim Diabetes Risk
In the diabetes news: diet and physical activity programs may help prevent type 2 DM, patiromer shows promise for hyperkalemia, metformin may treat portal hypertension.
Metformin Intolerance and Alternative Therapies Quiz
What is the best way to treat a diabetic patient who has a metformin intolerance? Test your knowledge of alternative monotherapies, including SGLT2 inhibitors, GLP-1 agonists, and sulfonylureas.
Metabolic Disease Research Roundup From AACE 2015
Metabolic disorders in patients with diabetes place them at particularly high risk for CV morbidity. Find insights on Dx and Tx in these slides.
Top 10 Reasons Why Patients Come to Primary Care
What brings patients to your office—and not the specialty office down the street? Insights in this slideshow.
Abridged Diabetes Guidelines for Primary Care: 6 Noteworthy Changes
The ADA provides an abridged version for PCPs of its annual Standards of Medical Care. Our slides summarize 6 updates important to primary care.
Five Top Papers From 2014 That Will Impact Your Practice
New drugs that treat stubborn illness seen often in primary care lead this group of Top 5 Papers for 2014. Type 2 diabetes, cryptogenic stroke, and hep-C are key targets.
By clicking Accept, you agree to become a member of the UBM Medica Community.